Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |